Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | -2.00% | +4.27% | -6.64% |
Financials (USD)
Sales 2024 * | 638M | Sales 2025 * | 739M | Capitalization | 9.37B |
---|---|---|---|---|---|
Net income 2024 * | 43M | Net income 2025 * | 88M | EV / Sales 2024 * | 14.3 x |
Net cash position 2024 * | 276M | Net cash position 2025 * | 386M | EV / Sales 2025 * | 12.2 x |
P/E ratio 2024 * |
317
x | P/E ratio 2025 * |
113
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.41% |
Latest transcript on Repligen Corporation
1 day | -2.00% | ||
1 week | +4.27% | ||
Current month | -8.73% | ||
1 month | -15.24% | ||
3 months | -7.64% | ||
6 months | +20.09% | ||
Current year | -6.64% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 167.9 | -2.00% | 545,959 |
24-04-23 | 171.3 | +8.76% | 928,614 |
24-04-22 | 157.5 | +0.22% | 294,448 |
24-04-19 | 157.1 | +0.05% | 386,770 |
24-04-18 | 157.1 | -2.44% | 759,238 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.64% | 9.37B | |
-2.89% | 185B | |
-2.43% | 107B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+3.86% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.40% | 25.66B |
- Stock Market
- Equities
- RGEN Stock